Kymera Therapeutics, Inc. — 8-K Filings
70 8-K filings on record
This page lists all 8-K filings submitted to the SEC by Kymera Therapeutics, Inc. (KYMR), sorted by most recent first. Each row links to the full filing on EdgarLookup. Kymera Therapeutics, Inc. has filed 70 8-K documents with the SEC since 2020. To view all SEC filings by Kymera Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-22-101673 | Apr 11, 2022 | Apr 6, 2022 |
| 8-K | 8-K | 0000950170-22-001858 | Feb 24, 2022 | — |
| 8-K | 8-K | 0001193125-22-011228 | Jan 18, 2022 | Jan 17, 2022 |
| 8-K | 8-K | 0001193125-21-367010 | Dec 27, 2021 | Dec 20, 2021 |
| 8-K | 8-K | 0001193125-21-358542 | Dec 16, 2021 | — |
| 8-K | 8-K | 0000950170-21-003909 | Nov 10, 2021 | — |
| 8-K | 8-K | 0001193125-21-308787 | Oct 27, 2021 | — |
| 8-K | 8-K | 0001193125-21-275102 | Sep 16, 2021 | — |
| 8-K | 8-K | 0001564590-21-041898 | Aug 6, 2021 | — |
| 8-K | 8-K | 0001193125-21-201090 | Jun 28, 2021 | — |
| 8-K | 8-K | 0001193125-21-193252 | Jun 17, 2021 | Jun 16, 2021 |
| 8-K | 8-K | 0001564590-21-024506 | May 6, 2021 | — |
| 8-K | 8-K | 0001193125-21-082817 | Mar 16, 2021 | Mar 12, 2021 |
| 8-K | 8-K | 0001193125-21-076998 | Mar 11, 2021 | — |
| 8-K | 8-K | 0001193125-21-064541 | Mar 2, 2021 | — |
| 8-K | 8-K | 0001193125-21-006774 | Jan 12, 2021 | — |
| 8-K | 8-K | 0001564590-20-050862 | Nov 5, 2020 | — |
| 8-K | 8-K | 0001193125-20-242218 | Sep 9, 2020 | Sep 4, 2020 |
| 8-K | 8-K | 0001193125-20-237224 | Sep 1, 2020 | Aug 27, 2020 |
| 8-K | 8-K | 0001193125-20-229873 | Aug 25, 2020 | Aug 20, 2020 |